Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
BPC-157 isn't FDA-approved as a pharmaceutical drug
Status Unapproved / public-health warning 2324 July 2026 Jurisdiction or evidence type United States / FDA PCAC Event Pharmacy Compounding Advisory Committee meeting scheduled to consider whether BPC-157 free base and acetate should be included on the 503A Bulks List
If your prescribed dose is 250mcg and your solution is 2,500mcg/ml, you need 0.1ml which reads as 10 units on the syringe
Sermorelin therapy stimulates the bodys natural growth hormone production to support systemic vitality, while BPC-157 promotes tissue healing and inflammation resolution at the local and cellular level
Quality Risks Outside Regulated Manufacture Incorrect BPC-157 salt or active moiety Full thymosin beta-4 substituted for TB-500 or the reverse Incorrect component ratio Peptide truncations and deletion sequences Oxidation, deamidation or hydrolysis Aggregation and possible immune responses Incorrect net peptide amount Unverified sterility or endotoxin control Batch documents that do not match the supplied vial Wolverine Stack UK Regulatory Position Regulatory information checked on 21 July 2026
US$ 26.12
US$ 24.89
US$ 28.96
US$ 27.89
US$ 27.55